House Bill 4667
116th Congress(2019-2020)
Biomedical Innovation Expansion Act of 2019
Introduced
Introduced in House on Oct 11, 2019
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
4667
Congress
116
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
No House votes have been held for this bill.
Summary
Biomedical Innovation Expansion Act of 2019
This bill expands and reauthorizes through FY2030 the National Institutes of Health innovation projects, which include the (1) All of Us Research Programs, (2) Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative, (3) Cancer Moonshot research, and (4) Regenerative Medicine Innovation Project. The bill also provides new funding for antimicrobial resistance research and for the research of rare diseases or conditions.
October 11, 2019
10/14/2019
Referred to the Subcommittee on Health.
10/11/2019
Referred to the House Committee on Energy and Commerce.
10/11/2019
Introduced in House
Public Record
Record Updated
Nov 1, 2022 1:49:41 PM